Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

BACKGROUND: Much progress has been made in understanding the role of catecholamines in the pathophysiology of posttraumatic stress disorder (PTSD). Recent research has broadened the scope of neuroregulation of PTSD to include serotonin. METHODS: We used the serotonin-releasing agent and reuptake inhibitor, d-fenfluramine, to assess the integrity of the serotonin-mediated prolactin release in 8 men with combat-induced PTSD and 8 healthy men. RESULTS: The veterans with PTSD had a significantly lower prolactin response to d-fenfluramine as compared to healthy control subjects. The prolactin response to d-fenfluramine was inversely correlated with the patient's level of PTSD symptomatology and measures of aggression. CONCLUSIONS: This study demonstrates a central serotonin dysfunction, as reflected in a lower prolactin response to d-fenfluramine, in patients with PTSD.

Type

Journal article

Journal

Biol Psychiatry

Publication Date

01/04/1999

Volume

45

Pages

928 - 930

Keywords

Analysis of Variance, Area Under Curve, Behavioral Symptoms, Case-Control Studies, Combat Disorders, Fenfluramine, Humans, Longitudinal Studies, Male, Middle Aged, Prolactin, Serotonin, Serotonin Agents, Single-Blind Method, Survivors, Time Factors, United States, Veterans, Vietnam